Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

34.99
Delayed Data
As of 4:04pm ET
 -0.25 / -0.71%
Today’s Change
34.52
Today|||52-Week Range
44.54
-9.14%
Year-to-Date

Today’s Trading

Previous close35.24
Today’s open35.04
Day’s range34.83 - 35.12
Volume4,680
Average volume (3 months)4,407,616
Market cap$87.5B
Data as of 4:04pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+15.74%
Earnings growth (next 5 years)+3.80%
Revenue growth (last year)+2.85%
P/E ratio27.7
Price/Sales2.52
Price/Book62.35

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.28+0.45%
NVONovo Nordisk-0.35-0.66%
LLYEli Lilly and Co+0.04+0.05%
CELGCelgene+1.17+1.08%
Data as of 4:15pm ET, 12/15/2017

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts